List of Figures
Figure 1: Biomarkers in Drug Discovery, Global, Biomarkers Facilitating Quick Turnover of Drugs, 2011
Figure 2: Biomarkers in Drug Discovery, Global Biomarkers Market, Revenue Forecast ($bn) 2002-2017
Figure 3: Biomarkers in Drug Discovery, Global, Commonly Identified Biomarkers, 2011
Figure 4: Biomarkers in Drug Discovery, Global, History of Biomarkers, 2011
Figure 5: Biomarkers in Drug Discovery, Global, Biomarkers Classification, Disease and Drug-related Biomarkers, 2011
Figure 6: Biomarkers in Drug Discovery, Global, Biomarker Categories, 2011
Figure 7: Biomarkers in Drug Discovery, Global, Types of Biomarkers, 2011
Figure 8: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Positive), 2011
Figure 9: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Positive), 2011
Figure 10: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Negative), 2011
Figure 11: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Negative or Positive), 2011
Figure 12: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail , 2011
Figure 13: Biomarkers in Drug Discovery, Global, Biomarker Discovery and Validation Process, 2009
Figure 14: Biomarkers in Drug Discovery, Global, General Application of Biomarkers, 2010
Figure 15: Biomarkers in Drug Discovery, Global, Role of Biomarkers in Drug Discovery and Development, 2011
Figure 16: Biomarkers in Drug Discovery, Global, Drug Discovery Process, 2011
Figure 17: Biomarkers in Drug Discovery, Global, Application of Biomarkers in Diagnosis, 2011
Figure 18: Biomarkers in Drug Discovery, Global, Potential Impact of Biomarkers on Disease States, 2011
Figure 19: Biomarkers in Drug Discovery, Global, Application of Biomarkers in Population Genetic Studies, 2011
Figure 20: Biomarkers in Drug Discovery, Global, Role of Biomarkers in Risk Assessment, 2011
Figure 21: Biomarkers in Drug Discovery, Global, Biomarkers Accelerate the Drug Discovery Process, 2011
Figure 22: Biomarkers in Drug Discovery, Global, Adoption of Biomarkers by Top Companies in Drug Discovery, 2011
Figure 23: Biomarkers in Drug Discovery, Global, Case Study, 2011
Figure 24: Biomarkers in Drug Discovery, Global Biomarkers Market, Revenue Forecast ($bn), 2002-2017
Figure 25: Biomarkers in Drug Discovery, Global Biomarkers Market, Market Segmentation by Therapy Area, 2011
Figure 26: Biomarkers in Drug Discovery, Global Biomarkers Drug Discovery Market, Revenue Forecast ($bn), 2002-2017
Figure 27: Biomarkers in Drug Discovery, Biomarkers Molecular Diagnostics Market, Revenue Forecast ($bn), 2002-2010
Figure 28: Biomarkers in Drug Discovery, Global Others Market, Revenue Forecast ($bn), 2002-2017
Figure 29: Biomarkers in Drug Discovery, Global Biomarkers Market Segmentation, 2011
Figure 30: Biomarkers in Drug Discovery, Global, Market Drivers and Restrains, 2011
Figure 31: Biomarkers in Drug Discovery, Global, Integration of ‘Omics’ Drive Global Biomarker Market, 2011
Figure 32: Biomarkers in Drug Discovery, Global, Biomarkers Fulfill Unmet Needs of Conventional Drug Discovery Methods, 2011
Figure 33: Biomarkers in Drug Discovery, Global, Reasons for Attrition, 2011
Figure 34: Biomarkers in Drug Discovery, Global, Biomarkers Technology Adoption Framework, 2011
Figure 35: Biomarkers in Drug Discovery, Global, Company Profile – Quest Diagnostics, 2011
Figure 36: Biomarkers in Drug Discovery, Quest Diagnostics, SWOT Analysis, 2011
Figure 37: Biomarkers in Drug Discovery, Global, Company Profile – Life Technologies, 2011
Figure 38: Biomarkers in Drug Discovery, Life Technologies, SWOT Analysis, 2011
Figure 39: Biomarkers in Drug Discovery, Global, Company Profile – Vermillion, 2011
Figure 40: Biomarkers in Drug Discovery, Vermillion, SWOT Analysis, 2011
Figure 41: Biomarkers in Drug Discovery, Global, Company Profile – BGMedicine, 2011
Figure 42: Biomarkers in Drug Discovery, BGMedicine, SWOT Analysis, 2011
Figure 43: Biomarkers in Drug Discovery, Global, Company Profile – Menarini, 2011
Figure 44: Biomarkers in Drug Discovery, Menarini, SWOT Analysis, 2011
Figure 45: Biomarkers in Drug Discovery, Global, Company Profile – Abbott, 2011
Figure 46: Biomarkers in Drug Discovery, Abbott, SWOT Analysis, 2011
Figure 47: Biomarkers in Drug Discovery, Global, Company Profile – Roche, 2011
Figure 48: Biomarkers in Drug Discovery, Roche, SWOT Analysis, 2011
Figure 49: Biomarkers in Drug Discovery, Global, Company Profile-Genentech, 2011
Figure 50: Biomarkers in Drug Discovery, Genentech, SWOT Analysis, 2011
Figure 51: Biomarkers in Drug Discovery, Global, Company Profile – Affymetrix, 2011
Figure 52: Biomarkers in Drug Discovery, Affymetrix, SWOT Analysis, 2011
Figure 53: Biomarkers in Drug Discovery, Global, Company Profile Amgen, 2011
Figure 54: Biomarkers in Drug Discovery, Amgen, SWOT Analysis, 2011
Figure 55: Biomarkers in Drug Discovery, Global, Geographic Landscape – Global Biomarkers Market, 2011
Figure 56: Biomarkers in Drug Discovery, Global, Pipeline Analysis by Phase, 2010
Figure 57: Biomarkers in Drug Discovery, Global, Pipeline Analysis by Therapeutic Class, 2011
Figure 58: Biomarkers in Drug Discovery, Global, Pipeline Analysis by Geography, 2011
Figure 59: Biomarkers in Drug Discovery, Global, Strategic Consolidations by Deal Type, 2010-2011
Figure 60: Biomarkers in Drug Discovery, Global, Strategic Consolidations, Mergers and Acquisitions by Geography (%), 2010-2011
Figure 61: Biomarkers in Drug Discovery, Global, Strategic Consolidations, Licensing Agreement Deals by Geography (%), 2010-2011